Malignant Peripheral Nervous System Neoplasm

Malignant Peripheral Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03989596	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas(SINDIR)	unknown	Phase 2	30	Maria Sklodowska-Curie National Research Institute of OncologyOTHER	1	Feb 1, 2021	clinicaltrials
NCT03651375	Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall(UN-RESARC)	unknown	Phase 2	46	Maria Sklodowska-Curie National Research Institute of Oncology